KELSEY GAID: Open Payments
NPI 1578096897 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,508 in 23 payments from 8 companies in 2025. Trend: 2023 $244 · 2024 $1,288 · 2025 $2,508
Food & beverage: $1,307Speaker / faculty: $960Travel & lodging: $176Education: $65
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 4 | $1,294 |
| Gilead Sciences, Inc. | 4 | $306 |
| CorMedix Inc. | 3 | $253 |
| Novo Nordisk Inc | 5 | $244 |
| Amgen Inc. | 3 | $174 |
| Madrigal Pharmaceuticals | 2 | $172 |
| Ardelyx, Inc. | 1 | $42 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
Products named: IQIRVO, DEFENCATH, REZDIFFRA, Wegovy, UPLIZNA, IBSRELA.
Industry payments across UT — which companies pay providers there.
